Endothelial dysfunction and atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease

被引:10
|
作者
Ciftel, Murat [1 ]
Simsek, Ayse [1 ]
Turan, Ozlem [1 ]
Kardelen, Firat [1 ]
Akcurin, Gayaz [1 ]
Ertug, Halil [1 ]
机构
[1] Akdeniz Univ, Dept Pediat Cardiol, Fac Med, Antalya, Turkey
关键词
Childhood; congenital heart disease; flow-mediated dilatation; pulmonary hypertension;
D O I
10.4103/0974-2069.99619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess endothelial dysfunction and the risk for coronary atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease (CHD). Methods: The study included 18 cyanotic patients (the mean age was 12.28 3.26 years) who developed irreversible pulmonary hypertension due to cyanotic and acyanotic CHDs, and 18 control patients (the mean age was 11.78 3.00 years). Study groups were compared for flow-mediated dilatation (FMD), carotid intima media thickness (CIMT) and atherosclerotic risk factors. Results: Compared to the control group, the mean FMD was significantly reduced in the cyanotic group (5.26 2.42% and 9.48 2.60%, respectively; P-value < 0.001). No significant difference was observed between the groups in CIMT (0.41 0.08 mm and 0.39 0.06 mm, respectively; P-value = 0.299). The levels of total cholesterol, low-density lipoprotein-cholesterol and very low-density lipoprotein-cholesterol were statistically significantly lower compared tothe control group (P-value = 0.001, 0.006 and 0.014, respectively), whereas no statistically significant difference was found in the levels of high-density lipoprotein-cholesterol and triglycerides (P-value = 0.113 and 0.975, respectively). Conclusions: Systemic endothelial dysfunction in children with irreversible pulmonary hypertension due to CHD was noted but there was no increased risk for atherosclerosis.
引用
收藏
页码:160 / 164
页数:5
相关论文
共 50 条
  • [1] PULMONARY HYPERTENSION IN CHILDREN DUE TO CONGENITAL HEART DISEASE
    ADAMS, FH
    JOURNAL OF PEDIATRICS, 1952, 40 (01): : 42 - 48
  • [2] Circulating endothelial cells are a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease
    Smadja, D. M.
    Gaussem, P.
    Mauge, L.
    Dignat-George, F.
    Bonnet, D.
    Levy, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 233 - 233
  • [3] Circulating Endothelial Cells A New Candidate Biomarker of Irreversible Pulmonary Hypertension Secondary to Congenital Heart Disease
    Smadja, David M.
    Gaussem, Pascale
    Mauge, Laetitia
    Israel-Biet, Dominique
    Dignat-George, Francoise
    Peyrard, Severine
    Agnoletti, Gabriella
    Vouhe, Pascal R.
    Bonnet, Damien
    Levy, Marilyne
    CIRCULATION, 2009, 119 (03) : 374 - 381
  • [4] ENDOTHELIAL DYSFUNCTION OCCURS EARLY IN THE PULMONARY CIRCULATION OF CHILDREN WITH CONGENITAL HEART-DISEASE
    CELERMAJER, DS
    CULLEN, S
    DEANFIELD, JE
    CIRCULATION, 1992, 86 (04) : 775 - 775
  • [5] Segmental Pulmonary Hypertension in Children with Congenital Heart Disease
    Das, Bibhuti B.
    Frank, Benjamin
    Ivy, Dunbar
    MEDICINA-LITHUANIA, 2020, 56 (10): : 1 - 11
  • [6] Apoptotic dysregulation in pulmonary hypertension due to congenital heart disease
    Levy, M.
    Bonnet, D.
    Vouhe, P. -R.
    ARCHIVES DE PEDIATRIE, 2008, 15 (05): : 698 - 701
  • [7] Ambrisentan for Pulmonary Arterial Hypertension Due to Congenital Heart Disease
    Zuckerman, Warren A.
    Leaderer, Derek
    Rowan, Cherise A.
    Mituniewicz, Johnell D.
    Rosenzweig, Erika Berman
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (09): : 1381 - 1385
  • [8] The relationship between endothelial progenitor cells and pulmonary arterial hypertension in children with congenital heart disease
    Hong-Xiao Sun
    Guo-Ju Li
    Zhan-Hui Du
    Zhen Bing
    Zhi-Xian Ji
    Gang Luo
    Si-Lin Pan
    BMC Pediatrics, 19
  • [9] The relationship between endothelial progenitor cells and pulmonary arterial hypertension in children with congenital heart disease
    Sun, Hong-Xiao
    Li, Guo-Ju
    Du, Zhan-Hui
    Bing, Zhen
    Ji, Zhi-Xian
    Luo, Gang
    Pan, Si-Lin
    BMC PEDIATRICS, 2019, 19 (01)
  • [10] Pulmonary Hypertension/Pulmonary arterial Hypertension in congenital Heart Disease and Therapy of pulmonary arterial Hypertension in Children
    Gorenflo, M.
    Apitz, C.
    Miera, O.
    Stiller, B.
    Schranz, D.
    Berger, F.
    Hager, A.
    Kaemmerer, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S166 - S170